Shastris
☆    

2010-04-14 08:13
(5922 d 09:13 ago)

Posting: # 5112
Views: 3,199
 

 ISR [Regulatives / Guidelines]

Dear all,
In multiple analyte projects, how are the samples selected for ISR for each analyte?

Would appreciate suggestions on the same

Regards,
Shastri
vajra123
☆    

India,
2010-04-14 08:21
(5922 d 09:05 ago)

@ Shastris
Posting: # 5114
Views: 2,660
 

 ISR

Dear Shastris,

Even in case of multianalyte, individual analyte will be coniserded for the acceptance. So in the selection of the ISR samples both the analytes has to be selected.


For Example:

If study containes Irbesartan and Hydrochlorothiazide, for the both the Cmax values and Tmax will different. So for irbesartan selected samples which are near by the Cmax and for Hydrochlorothiazide Viceversa.

below is the link which may be useful.
http://www.ema.europa.eu/pdfs/human/ewp/19221709en.pdf

Regards,
Vajra123

Vajra
Shastris
☆    

2010-04-14 17:21
(5922 d 00:04 ago)

@ vajra123
Posting: # 5134
Views: 2,601
 

 ISR

Dear Vajra,
Thank you for the response.

I was actually looking at a situation where in analyte and metabolite/s OR 2 or more than 2 analytes are quantified simultaneously. (Difference in Tmax may or may not be less than an hour)

In such instances how will the samples be selected for each analyte/metabolite/s?

Also as per the white paper, samples need to be selected for each analyte.

If the samples are picked for each analyte, then do we look at the data for the other analyte (analyte 2) from this set also OR do we stick to ISR results from the samples actually picked for Analyte 2?

E.g: Simultaneous analysis of Stavudine and Lamivudine

Samples picked for Stavudine. ISR passes. Lamivudine results from this set of samples also to be looked into? What if it fails?

Samples picked for lamivudine. ISR passes. Stavudine results from this set of data also to be looked into? What if it fails?

Request comments on the same

Regards,
Shastri
vajra123
☆    

India,
2010-04-15 07:07
(5921 d 10:19 ago)

@ Shastris
Posting: # 5145
Views: 2,604
 

 ISR

Dear Shastris,


As I told you earlier the selection of the samples entirely depends on the in house specifications. For example you can select the 2 or 3 time points at the Cmax from each period.

As the ISR will be performed for the method reproducubility. so when there is a simultaneous method like as you said Stavudine and Lamivudine eventhough we select the samples for the Stavudine ISR and the data of the lamivudine will also be looked for the acceptance.

If the Method is quantifying 2 or more than each analyte ISR has to be done, If protocol,defines all the three analytes to be estimated. Then for all the analytes ISR has to be performed.

If the data of lamvudine fails :no: when your doing the Stavudine ISR or viceversa question will be raised from the regualotres :blahblah:.

I like to share my personel experience. once we had a FDA in our facility. Method is simultatneous. The auditor has asked for the comparsion of the data from the passed one to the failed one.(for example if stavudine fails in the batch and it is repeated, the repeated results are compared to the failed batch).

I hope you got the information which you needed.

If am wrong please correct me.

Regards, :ok:

Vajra
Shastris
☆    

2010-04-16 12:06
(5920 d 05:20 ago)

@ vajra123
Posting: # 5151
Views: 2,563
 

 ISR

Dear Vajra,
Thank you for the detailed response :ok:

Regards,
Shastri
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
251 visitors (0 registered, 251 guests [including 17 identified bots]).
Forum time: 17:26 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5